Skinvisible, Inc. (SKVI) Partnership with Quoin Focuses on Population’s Pain Needs
Non-binding proposed merger announced on November 27, 2017 Quoin merger expected to deliver non-opioid relief to post-surgical patients Over-65 population with advanced pain needs expected to double within next 30 years Skinvisible and Quoin proposed merger expected to deliver better results to patients Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted…
